Literature DB >> 15902963

Cisplatin-induced renal interstitial fibrosis in neonatal rats, developing as solitary nephron unit lesions.

Jyoji Yamate1, Yuuko Machida, Mika Ide, Mitsuru Kuwamura, Takao Kotani, Osamu Sawamoto, Jonathan LaMarre.   

Abstract

Cisplatin (CDDP)-induced renal lesions in rats prove a useful model for analysis of the pathogenesis of post-tubular injury-renal interstitial fibrosis. This study investigated the histopathological changes in 10-day-old neonatal rats induced by a single injection of CDDP (4.5 mg/kg). Compared with age-matched controls, on postinjection (PI) days 1 to 6, the number of apoptotic cells, demonstrable with TUNEL method, was significantly increased in CDDP-treated neonates, and there was no marked epithelial necrosis nor fibrotic lesions. Fibrotic lesions began to be developed solitarily around some nephrons with dilated ducts in the corticomedullary junction on PI day 10 and the lesions became more prominent until PI day 20. The alpha-SMA-positive myofibroblastic cells were seen exclusively in the fibrotic lesions. Additionally, the numbers of macrophages reacting with EDI (specific for exudate macrophages), ED2 (for resident macrophages), and OX6 (recognizing MHC class II antigens expressed in antigen-presenting macrophages/dendritic cells) were significantly increased around the affected renal tubules. A greater immunoreaction for TGF-beta1 was seen mostly in the renal epithelial cells of CDDP-treated neonates. These findings indicated that macrophage populations and myofibrolastic cells as well as TGF-beta1 may be responsible for the production of neonatal renal interstitial fibrosis. Compared with CDDP-injected adult rats that develop extensive interstitial fibrosis (Yamate et al., J Comp Pathol, 1995), the formation of fibrotic lesions was delayed, and the lesions were limited to the area around the affected nephrons; this could be attributable to differences in renal morphology between neonates and mature kidney of adult rats.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15902963     DOI: 10.1080/01926230490523978

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  9 in total

1.  Nephroprotective effect of bee honey and royal jelly against subchronic cisplatin toxicity in rats.

Authors:  Abdelazim Ibrahim; Mabrouk A Abd Eldaim; Mohamed M Abdel-Daim
Journal:  Cytotechnology       Date:  2015-02-27       Impact factor: 2.058

2.  Nephroprotective efficacy of ceftriaxone against cisplatin-induced subchronic renal fibrosis in rats.

Authors:  Mohamed M Abdel-Daim; Yasser S El-Sayed; Mabrouk Abd Eldaim; Abdelazim Ibrahim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-12-14       Impact factor: 3.000

3.  Comparative nephrotoxicity of Cisplatin and nedaplatin: mechanisms and histopathological characteristics.

Authors:  Takeki Uehara; Jyoji Yamate; Mikinori Torii; Toshiyuki Maruyama
Journal:  J Toxicol Pathol       Date:  2011-06-30       Impact factor: 1.628

4.  Immunohistochemical analyses of the kinetics and distribution of macrophages in the developing rat kidney.

Authors:  Satoshi Matsuyama; Mohammad Rabiul Karim; Takeshi Izawa; Mitsuru Kuwamura; Jyoji Yamate
Journal:  J Toxicol Pathol       Date:  2018-05-03       Impact factor: 1.628

5.  Coleus amboinicus extract increases transforming growth factor-1β expression in Wistar rats with cisplatin-induced nephropathy.

Authors:  Iwan Sahrial; Rondius Solfaine
Journal:  Vet World       Date:  2019-08-28

6.  Acetaminophen-Induced Rat Hepatotoxicity Based on M1/M2-Macrophage Polarization, in Possible Relation to Damage-Associated Molecular Patterns and Autophagy.

Authors:  Yuka Tsuji; Mizuki Kuramochi; Hossain M Golbar; Takeshi Izawa; Mitsuru Kuwamura; Jyoji Yamate
Journal:  Int J Mol Sci       Date:  2020-11-26       Impact factor: 5.923

Review 7.  TGF-β1 Signaling: Immune Dynamics of Chronic Kidney Diseases.

Authors:  Philip Chiu-Tsun Tang; Alex Siu-Wing Chan; Cai-Bin Zhang; Cristina Alexandra García Córdoba; Ying-Ying Zhang; Ka-Fai To; Kam-Tong Leung; Hui-Yao Lan; Patrick Ming-Kuen Tang
Journal:  Front Med (Lausanne)       Date:  2021-02-25

8.  Farnesoid X receptor ligand prevents cisplatin-induced kidney injury by enhancing small heterodimer partner.

Authors:  Eun Hui Bae; Hong Sang Choi; Soo Yeon Joo; In Jin Kim; Chang Seong Kim; Joon Seok Choi; Seong Kwon Ma; Jongun Lee; Soo Wan Kim
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

Review 9.  Cisplatin-Induced Rodent Model of Kidney Injury: Characteristics and Challenges.

Authors:  Martina Perše; Željka Večerić-Haler
Journal:  Biomed Res Int       Date:  2018-09-12       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.